Concepedia

S. Bouchillon

SB

Statistics

Publications

28

Citations

1.4K

H-Index

19

Active since

1993

Affiliations

GlaxoSmithKline (United States)(Current)

Pfizer (United States)

TES International (United States)

University School

Case Western Reserve University

S. Bouchillon is an author at GlaxoSmithKline (United States) specializing in medical microbiology, infectious diseases, and antibiotic resistance.

Publications per year

1993–2016

28

Publications

28

Increasing prevalence and dissemination of NDM-1 metallo- -lactamase in India: data from the SMART study (2009)

Christine Lascols, Meredith Hackel, Steve H. Marshall et al. · Journal of Antimicrobial Chemotherapy · 2011 · 165 citations · Full text

, , +17

Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002

S. Bouchillon, Brian Johnson, D. Hoban et al. · International Journal of Antimicrobial Agents · 2004 · 141 citations

, , +17

<i>In Vitro</i> Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens

Douglas J. Biedenbach, S. Bouchillon, Meredith Hackel et al. · Antimicrobial Agents and Chemotherapy · 2016 · 139 citations · Full text

, , +17

Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations

Meredith Hackel, Christine Lascols, S. Bouchillon et al. · Vaccine · 2013 · 121 citations

, , +17

Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase–producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009–2010

Daryl J. Hoban, Christine Lascols, Lindsay E. Nicolle et al. · Diagnostic Microbiology and Infectious Disease · 2012 · 116 citations

, , +17

1–5 of 28